Public health campaign to improve melanoma awareness in Oregon
Educational Program for the Early Detection of Melanoma in Oregon
This study is testing if a public health campaign can help people in Oregon understand melanoma better and improve their chances of early diagnosis and treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 75000 (estimated) |
| Ages | 12 Years and up |
| Sex | All |
| Sponsor | OHSU Knight Cancer Institute Academic / other |
| Locations | 1 site (Portland, Oregon) |
| Trial ID | NCT04611568 on ClinicalTrials.gov |
What this trial studies
This initiative aims to evaluate the effectiveness of a health educational campaign designed to enhance melanoma literacy among residents in Oregon. The campaign includes digital media strategies, online curricula for primary care providers, and educational lectures for high school students. By measuring changes in knowledge and awareness over five years, the study seeks to determine the impact of increased education on melanoma diagnosis stages, tumor depth, incidence, and mortality rates. Additionally, it will assess whether improved literacy affects the cost of melanoma care in the region.
Who should consider this trial
Good fit: Ideal candidates include individuals living in Oregon, particularly those interested in melanoma awareness, including patients, healthcare providers, and high school students.
Not a fit: Patients who are not residents of Oregon or those who are not engaged in melanoma awareness may not benefit from this campaign.
Why it matters
Potential benefit: If successful, this campaign could lead to earlier detection of melanoma, potentially reducing mortality rates associated with the disease.
How similar studies have performed: Other educational campaigns have shown success in improving health literacy and early detection rates for various conditions, suggesting a positive outlook for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals, melanoma patients, skin service providers and health care providers interested in awareness and educational campaign Exclusion Criteria: * No one will be intentionally excluded
Where this trial is running
Portland, Oregon
- OHSU Knight Cancer Institute — Portland, Oregon, United States (Recruiting)
Study contacts
- Principal investigator: Sancy A Leachman, MD, PhD — OHSU Knight Cancer Institute
- Study coordinator: Elizabeth Stoos
- Email: stoos@ohsu.edu
- Phone: 503-418-9356
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.